124 related articles for article (PubMed ID: 10224464)
41. Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor.
Welker P; Grabbe J; Gibbs B; Zuberbier T; Henz BM
Scand J Immunol; 1999 May; 49(5):495-500. PubMed ID: 10320642
[TBL] [Abstract][Full Text] [Related]
42. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
Goldstein SM; Leong J; Schwartz LB; Cooke D
J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
[TBL] [Abstract][Full Text] [Related]
43. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase.
Mizutani H; Schechter N; Lazarus G; Black RA; Kupper TS
J Exp Med; 1991 Oct; 174(4):821-5. PubMed ID: 1919436
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of histamine release from human mast cells by natural chymase inhibitors.
He SH; Xie H; Zhang XJ; Wang XJ
Acta Pharmacol Sin; 2004 Jun; 25(6):822-6. PubMed ID: 15169639
[TBL] [Abstract][Full Text] [Related]
45. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents.
Taylor AM; Galli SJ; Coleman JW
Immunology; 1995 Nov; 86(3):427-33. PubMed ID: 8550081
[TBL] [Abstract][Full Text] [Related]
46. Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.
Pejler G
J Innate Immun; 2020; 12(5):357-372. PubMed ID: 32498069
[TBL] [Abstract][Full Text] [Related]
47. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
48. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
Badertscher K; Brönnimann M; Karlen S; Braathen LR; Yawalkar N
Arch Dermatol Res; 2005 Apr; 296(10):503-6. PubMed ID: 15703960
[TBL] [Abstract][Full Text] [Related]
49. The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase.
Buckley MG; McEuen AR; Walls AF
J Pathol; 1999 Sep; 189(1):138-43. PubMed ID: 10451500
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
51. Biological functions of serine proteases in mast cells in allergic inflammation.
Katunuma N; Kido H
J Cell Biochem; 1988 Dec; 38(4):291-301. PubMed ID: 2467915
[TBL] [Abstract][Full Text] [Related]
52. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
53. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase.
Fang KC; Raymond WW; Lazarus SC; Caughey GH
J Clin Invest; 1996 Apr; 97(7):1589-96. PubMed ID: 8601622
[TBL] [Abstract][Full Text] [Related]
54. Extended cleavage specificity of the mast cell chymase from the crab-eating macaque (Macaca fascicularis): an interesting animal model for the analysis of the function of the human mast cell chymase.
Thorpe M; Yu J; Boinapally V; Ahooghalandari P; Kervinen J; Garavilla Ld; Hellman L
Int Immunol; 2012 Dec; 24(12):771-82. PubMed ID: 22949566
[TBL] [Abstract][Full Text] [Related]
55. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.
Schick B
Immunology; 1990 Mar; 69(3):423-8. PubMed ID: 2312165
[TBL] [Abstract][Full Text] [Related]
56. Mast cell proteoglycans modulate the secretagogue, proteoglycanase, and amidolytic activities of dog mast cell chymase.
Sommerhoff CP; Ruoss SJ; Caughey GH
J Immunol; 1992 May; 148(9):2859-66. PubMed ID: 1573274
[TBL] [Abstract][Full Text] [Related]
57. Human mast cell heterogeneity.
Irani AM; Schwartz LB
Allergy Proc; 1994; 15(6):303-8. PubMed ID: 7721078
[TBL] [Abstract][Full Text] [Related]
58. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro.
Dvorak AM; Seder RA; Paul WE; Morgan ES; Galli SJ
Am J Pathol; 1994 Jan; 144(1):160-70. PubMed ID: 7507298
[TBL] [Abstract][Full Text] [Related]
59. Translation and granule localization of mouse mast cell protease-5. Immunodetection with specific antipeptide Ig.
McNeil HP; Frenkel DP; Austen KF; Friend DS; Stevens RL
J Immunol; 1992 Oct; 149(7):2466-72. PubMed ID: 1527387
[TBL] [Abstract][Full Text] [Related]
60. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
